Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-17 3:05 pm Sale | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-16 2:19 pm Sale | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,058,505 11.000% | -679,701 (-10.09%) | View |
| 2020-02-14 5:00 pm Sale | 13G | ARQULE INC ARQL | BIOTECHNOLOGY VALUE FUND L P | 4,902,383 4.000% | -3,767,967 (-43.46%) | View |
| 2020-02-14 12:19 pm Purchase | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,738,206 5.560% | 6,738,206 (New Position) | View |
| 2020-02-12 5:02 pm Sale | 13G | ARQULE INC ARQL | INTEGRATED CORE STRATEGIES (US) LLC | 1,308,382 1.100% | -4,160,435 (-76.08%) | View |
| 2020-02-12 12:04 pm Purchase | 13G | ARQULE INC ARQL | VANGUARD GROUP INC | 5,917,567 4.890% | 451,709 (+8.26%) | View |
| 2020-02-10 1:42 pm Sale | 13G | ARQULE INC ARQL | Nantahala Capital Management LLC | 0 0.000% | -6,544,347 (Position Closed) | View |
| 2020-02-05 11:25 am Purchase | 13G | ARQULE INC ARQL | BlackRock Inc. BLK | 10,009,684 8.300% | 1,391,672 (+16.15%) | View |
| 2020-01-10 4:01 pm Sale | 13G | ARQULE INC ARQL | Nantahala Capital Management LLC | 6,544,347 5.400% | -6,092,775 (-48.21%) | View |
| 2020-01-09 4:15 pm Sale | 13G | ARQULE INC ARQL | Bleichroeder LP | 2,750,000 2.280% | -13,178,628 (-82.74%) | View |
| 2019-12-16 5:12 pm Purchase | 13D | ARQULE INC ARQL | Merck & Co. Inc. MRK | 17,481,903 12.600% | 17,481,903 (New Position) | View |